Infusion administration billing for vedolizumab and infliximab in inflammatory bowel disease
Author:
Affiliation:
1. Takeda Pharmaceuticals USA Inc., Deerfield, IL, USA;
2. Institute for Clinical and Economic Review, Boston, MA, USA
Publisher
Informa UK Limited
Subject
Health Policy
Link
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2018.1511568
Reference34 articles.
1. Pharmacy Benefit Management Institute. Specialty Drug Benefit Report 2015. Available at: https://www.pbmi.com/shop/reports/2015-specialty-drug-benefit-report [Last accessed 2 March 2017]
2. A medicoeconomic review of early intervention with biologic agents in the treatment of inflammatory bowel diseases
3. Evaluating the administration costs of biologic drugs: development of a cost algorithm
4. Pharmacy Benefit Management Institute. Specialty Drug Benefit Report 2013. Available at: https://www.pbmi.com/shop/reports/2013-specialty-drug-benefit-report [Last accessed 2 March 2017]
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A strategy to identify event specific hospitalizations in large health claims databases;BMC Health Services Research;2022-05-26
2. Real-World Persistence, Maintenance Dosing, and Pre-Post Corticosteroid and Opioid Use Among Crohn’s Disease Patients with Prescription Claims for Ustekinumab in the USA;Drugs - Real World Outcomes;2021-06-16
3. The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn’s Disease in the Biosimilar Era;Inflammatory Bowel Diseases;2019-09-18
4. Health Care Cost for Children Newly Diagnosed With Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2019-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3